Iovance Biotherapeutics, Inc.IOVANASDAQ
Loading
Cash generated from core business operations
Latest
$-302.41M
↓ 43% vs avg
Percentile
P14
Within normal range
Streak
2 yr
Consecutive growthContracting
Average
$-211.46M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | $-302.41M | +14.3% |
| 2024 | $-352.98M | +2.4% |
| 2023 | $-361.82M | -23.6% |
| 2022 | $-292.76M | -28.4% |
| 2021 | $-227.94M | -11.1% |
| 2020 | $-205.13M | -29.1% |
| 2019 | $-158.89M | -56.9% |
| 2018 | $-101.25M | -28.6% |
| 2017 | $-78.71M | -140.9% |
| 2016 | $-32.67M | - |